Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma

Multiple myeloma is a prevalent and incurable disease, despite the development of new and effective drugs. The recent development of chimeric antigen receptor (CAR)T cells has shown impressive results in the treatment of patients with relapsed or refractory hematologic B-cell malignancies. In recent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Perez-Amill, Lorena, Suñe, Guillermo, Antoñana-Vildosola, Asier, Castella, Maria, Najjar, Amer, Bonet, Jaume, Fernández-Fuentes, Narcis, Inogés, Susana, López, Ascensión, Bueno, Clara, Juan, Manel, Urbano-Ispizua, Alvaro, Martín-Antonio, Beatriz
Format: Artigo
Idioma:Inglês
Publicat: Fondazione Ferrata Storti 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776337/
https://ncbi.nlm.nih.gov/pubmed/31919085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.228577
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars